Open Access

[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway

  • Authors:
    • Jiaguo Liu
    • Bin Luo
    • Meng Zhao
  • View Affiliations

  • Published online on: March 13, 2023     https://doi.org/10.3892/mmr.2023.12978
  • Article Number: 91
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

April-2023
Volume 27 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Luo B and Zhao M: [Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway. Mol Med Rep 27: 91, 2023.
APA
Liu, J., Luo, B., & Zhao, M. (2023). [Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway. Molecular Medicine Reports, 27, 91. https://doi.org/10.3892/mmr.2023.12978
MLA
Liu, J., Luo, B., Zhao, M."[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway". Molecular Medicine Reports 27.4 (2023): 91.
Chicago
Liu, J., Luo, B., Zhao, M."[Retracted] Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway". Molecular Medicine Reports 27, no. 4 (2023): 91. https://doi.org/10.3892/mmr.2023.12978